Dihydrocodeine
Aliases: dhc
Summary
Dihydrocodeine is a semi-synthetic morphinan opioid analgesic prescribed for pain, or as an antitussive (either alone or compounded with paracetamol or aspirin). It was developed in Germany in 1908 and first marketed in 1911.
Dose Information
| ROA | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| Oral | 50-100mg | 100-150mg | 150-200mg | 200mg+ |
Onset, Duration & After-effects
| ROA | Onset | Peak | Offset | Total |
|---|---|---|---|---|
| Oral | 30-45 min | 3-4 hrs | 60-90 min | 4.5-6.2 hrs |
Opioid MME Calculator
| Substance | Equivalent Dose | MME Factor |
|---|
⚠ Equianalgesic dose ratios are approximations and do not account for genetic factors, tolerance, incomplete cross-tolerance, or pharmacokinetic variations. Methadone conversion is especially variable at higher doses. Always consult a healthcare provider before making any changes to opioid therapy.
Effect Profile
15 reportsScores (1–10) curated from multiple sources:
- Effect keyword matching from PsychonautWiki catalog
- Weighted by importance: core (×3), major (×2), minor (×1)
Strong euphoria with moderate itching/nausea, mild pain relief and sedation
Tolerance
Tolerance Decay
Tolerance develops rapidly with near‑daily use and decays over days to weeks after cessation. After a break, prior doses can overshoot—restart with markedly lower doses to reduce overdose risk. Cross‑tolerance exists across mu‑agonist opioids but is incomplete.
Cross-Tolerances
Effects
Aggregated from 15 Erowid experience reports